Lorlatinib
Brand name: Lorbrena
Rank #481 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.7M
Total Cost
720
Total Claims
$14.7M
Total Cost
51
Prescribers
$20K
Cost per Claim
0
Beneficiaries
722
30-Day Fills
$287K
Avg Cost/Provider
14
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.7M total
🔎 Data Overview
At $20,356 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $287,378 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Lorlatinib
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mali Amirault | Nurse Practitioner | Aurora, CO | 32 | $737K |
| 2 | Hannah Tualla | Nurse Practitioner | Los Angeles, CA | 25 | $530K |
| 3 | Khrister-Nikka Berkowitz | Nurse Practitioner | Los Angeles, CA | 24 | $528K |
| 4 | Nicholas Rohs | Medical Oncology | New York, NY | 19 | $498K |
| 5 | Kathryn Gold | Medical Oncology | La Jolla, CA | 22 | $443K |
| 6 | Petros Nikolinakos | Medical Oncology | Athens, GA | 18 | $400K |
| 7 | Benjamin Newton | Hematology-Oncology | Waterford, CT | 17 | $381K |
| 8 | Shahrooz Eshaghian | Hematology-Oncology | Los Angeles, CA | 16 | $367K |
| 9 | Fernando Santini | Medical Oncology | West Harrison, NY | 17 | $364K |
| 10 | Benjamin Creelan | Medical Oncology | Tampa, FL | 17 | $359K |
| 11 | Konstantinos Arnaoutakis | Hematology-Oncology | Little Rock, AR | 16 | $317K |
| 12 | Alan Kramer | Hematology-Oncology | San Francisco, CA | 15 | $317K |
| 13 | Hirva Mamdani | Hematology-Oncology | Detroit, MI | 16 | $314K |
| 14 | Scott Lunin | Medical Oncology | Sarasota, FL | 14 | $308K |
| 15 | Mark Kris | Medical Oncology | New York, NY | 23 | $306K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 478 | Raloxifene Hcl (Raloxifene Hcl) | $14.8M | 198,063 |
| 479 | Lanthanum Carbonate (Lanthanum Carbonate) | $14.7M | 13,783 |
| 480 | Mometasone Furoate (Mometasone Furoate) | $14.7M | 266,966 |
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology